Triiodothyronine tests
This article was originally published in The Gray Sheet
Executive Summary
Oct. 18 FDA final rule exempts from premarket 510(k) notification requirements triiodothyronine (T3) test systems indicated for measuring the hormone T3 in serum and plasma. The rule grants a petition request from Abbott (1"The Gray Sheet" July 24, 2000, p. 11)